European Commission: Revlimid approved for the treatment of relapsed / refractory patients with mantle cell lymphoma
The European Commission ( EC ) has approved Revlimid ( Lenalidomide ) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma ( MCL ).
Mantle cell lymphoma is a rare su ...
read article